Judith Hahn

Professor Judith Hahn is a faculty member at the University of California, San Francisco (UCSF), affiliated with the Department of Medicine. Her academic rank is Professor, focusing on epidemiology and global health, particularly at the intersection of substance use and infectious diseases like HIV/AIDS and tuberculosis (TB). Her NIH-funded research includes studies on alcohol consumption’s impact on HIV care outcomes, TB preventive therapy adherence, and intervention development for vulnerable populations in sub-Saharan Africa and the U.S.

Her research team leads the Uganda Alcohol Research Collaboration on HIV (ARCH) cohort, examining biomarkers of alcohol use (e.g., phosphatidylethanol) and behavioral interventions. Key projects include the Masibambisane trial (couples-based alcohol reduction), the Mlambe economic intervention for Malawian couples, and studies on HIV/TB coinfection among heavy drinkers. She collaborates extensively with global institutions, addressing issues like stigma, intimate partner violence, and pandemic-related health disruptions.

Professor Hahn’s work emphasizes innovative methods, such as telemedicine adaptations during the pandemic and mobile health (mHealth) tools. Her studies often integrate qualitative insights with quantitative data, prioritizing marginalized groups like youth, pregnant women, and unhoused populations. Despite no explicit mention of awards, her contributions have advanced HIV care strategies in resource-limited settings.

Her grants include NIH R01 funding for Uganda-based studies and collaborations with organizations like JCI Insight and the Lancet. She leads teams in Uganda, Malawi, South Africa, and Russia, with a focus on translating research into scalable interventions. Future directions include expanding the ARCH cohort and exploring biomarkers for substance use in global health contexts.